2011
DOI: 10.1038/labinvest.2011.135
|View full text |Cite
|
Sign up to set email alerts
|

mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome

Abstract: Although podocyte damage is known to be responsible for the development of minimal-change disease (MCD), the underlying mechanism remains to be elucidated. Previously, using a rat MCD model, we showed that endoplasmic reticulum (ER) stress in the podocytes was associated with the heavy proteinuric state and another group reported that a mammalian target of rapamycin complex 1 (mTORC1) inhibitor protected against proteinuria. In this study, which utilized a rat MCD model, a combination of immunohistochemistry, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
46
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(49 citation statements)
references
References 39 publications
(47 reference statements)
2
46
0
1
Order By: Relevance
“…4 Recent evidence has suggested a robust increase in podocyte BiP due to ER stress caused by Pierson syndrome (laminin mutations), Alport syndrome, thin membrane basement disease (collagen IV mutations), Heymann nephritis, puromcyin-induced nephrosis, and mesangioproliferative GN. [5][6][7][8] Therefore, in the current study, we first verified that treatment of cultured podocytes with tunicamycin, an agent that inhibits N-glycosylation of proteins in the ER, results in an increase in ER stress and activation of the UPR. This effect was further validated in vivo by glomeruli isolated from mice injected with rabbit-anti-mouse glomerular basement membrane nephrotoxic sera (NTS).…”
mentioning
confidence: 64%
See 1 more Smart Citation
“…4 Recent evidence has suggested a robust increase in podocyte BiP due to ER stress caused by Pierson syndrome (laminin mutations), Alport syndrome, thin membrane basement disease (collagen IV mutations), Heymann nephritis, puromcyin-induced nephrosis, and mesangioproliferative GN. [5][6][7][8] Therefore, in the current study, we first verified that treatment of cultured podocytes with tunicamycin, an agent that inhibits N-glycosylation of proteins in the ER, results in an increase in ER stress and activation of the UPR. This effect was further validated in vivo by glomeruli isolated from mice injected with rabbit-anti-mouse glomerular basement membrane nephrotoxic sera (NTS).…”
mentioning
confidence: 64%
“…22 This fundamental machinery is also elicited in podocytes; previous reports have revealed increased expression of molecular chaperones and the UPR in vitro after albumin administration 23,24 and in vivo after experimental glomerular injury in rodents. 7,8,25 Furthermore, upregulation of ER stress proteins in human kidney biopsy specimens taken from patients harboring laminin and collagen IV mutations, 7,8 patients with underlying diabetic nephropathy, 26,27 and patients with FSGS 28,29 suggests the fundamental role of the UPR in podocyte biology. The GRP78 activation observed in a variety of glomerular diseases is likely an adaptive cellular process, which meets the demands of a pathologic condition and may arise irrespective of disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…6 ER stress occurs when homeostasis is disturbed. It can be induced by hyperglycemia, reactive oxygen species (ROS), free fatty acids and other mediators in the presence of diabetes, 7 with the accumulation of unfolded proteins in ER.…”
mentioning
confidence: 99%
“…Increased mTOR activity has been reported in different glomerular diseases, and mTORC1 inhibition by rapamycin and everolimus shows beneficial effects against diabetic nephropathy, focal segmental glomerulosclerosis, minimal change disease, membranous nephropathy, etc. (7)(8)(9)(10). But contrasting evidence also indicates that mTORC1 inhibition by the immunosuppressive drug rapamycin leads proteinuria and podocyte apoptosis and develops primary focal segmental glomerulosclerosis in renal transplant recipients (11).…”
mentioning
confidence: 99%